Soriano CR, Powell CR, Chiorean MV, Simianu VV. Role of hospitalization for inflammatory bowel disease in the post-biologic era. World J Clin Cases 2021; 9(26): 7632-7642 [PMID: 34621815 DOI: 10.12998/wjcc.v9.i26.7632]
Corresponding Author of This Article
Vlad V Simianu, MD, Surgeon, Department of Surgery, Virginia Mason Franciscan Health, 1100 9th Ave, C6-GS, Seattle, WA 98101, United States. val.simianu@virginiamason.org
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Sep 16, 2021; 9(26): 7632-7642 Published online Sep 16, 2021. doi: 10.12998/wjcc.v9.i26.7632
Role of hospitalization for inflammatory bowel disease in the post-biologic era
Celine R Soriano, Charleston R Powell, Michael V Chiorean, Vlad V Simianu
Celine R Soriano, Vlad V Simianu, Department of Surgery, Virginia Mason Franciscan Health, Seattle, WA 98101, United States
Charleston R Powell, Department of Internal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, United States
Michael V Chiorean, Department of Gastroenterology, Swedish Medical Center, Seattle, WA 98109, United States
Author contributions: Soriano CR and Simianu VV contributed to the concept of the review; Soriano CR and Powell CR performed the literature review; Soriano CR and Powell CR contributed to manuscript preparation and draft; Soriano CR, Powell CR, Chiorean MV and Simianu VV contributed edits and revisions to the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare no conflicts of interest. The views expressed are those of the author(s) and do not reflect the official policy of the Department of the Army, the Department of Defense or the U.S. Government.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Vlad V Simianu, MD, Surgeon, Department of Surgery, Virginia Mason Franciscan Health, 1100 9th Ave, C6-GS, Seattle, WA 98101, United States. val.simianu@virginiamason.org
Received: March 19, 2021 Peer-review started: March 19, 2021 First decision: May 4, 2021 Revised: May 17, 2021 Accepted: August 12, 2021 Article in press: August 12, 2021 Published online: September 16, 2021
Abstract
Treatment for inflammatory bowel disease (IBD) often requires specialized care. While much of IBD care has shifted to the outpatient setting, hospitalizations remain a major site of healthcare utilization and a sizable proportion of patients with inflammatory bowel disease require hospitalization or surgery during their lifetime. In this review, we approach IBD care from the population-level with a specific focus on hospitalization for IBD, including the shifts from inpatient to outpatient care, the balance of emergency and elective hospitalizations, regionalization of specialty IBD care, and contribution of surgery and endoscopy to hospitalized care.
Core Tip: Inflammatory bowel disease (IBD)-related hospitalizations are costly and have increased despite the introduction of advanced therapeutic agents. Over the past few decades, utilization of endoscopy and emergency surgery during hospital admissions have decreased, with a concomitant rise in elective bowel resections. With increased complexity of inpatient and outpatient management of IBD, improved care delivery and outcomes may consist of multidisciplinary teams led by IBD specialists, regionalization, and IBD-specific treatment plans.
